Information Provided By:
Fly News Breaks for March 30, 2015
RHHBY, AZN, SHPG, BMRN
Mar 30, 2015 | 07:48 EDT
After several media outlets reported that Shire (SHPG), AstraZeneca (AZN) and Roche (RHHBY) are considering buying BioMarin (BMRN), SunTrust says that it would be logical for several drug companies looking to build or expand their orphan disease franchises to buy BioMarin. The firm keeps a Buy rating on BioMarin.